NOTICE OF THE ANNUAL GENERAL MEETING

Notice  is given to the shareholders of  Revenio Group Corporation of the annual
general meeting to be held on 3/19/2015, at 4 p.m. at Finlandia Hall, Veranda 4
hall,  Mannerheimintie 13 e,  FI-00100 Helsinki, Finland  (entrances M4 and K4).
The   reception  of  persons  who  have  registered  for  the  meeting  and  the
distribution of voting tickets will commence at 2.30 p.m.

Before  the  meeting  at  3 p.m.,  Olli-Pekka  Salovaara,  CEO  of Revenio Group
Corporation  and Timo Hilden, CEO of Icare  Finland Oy, will give a presentation
on Revenio Group Corporation's R&D projects. After the annual general meeting is
held,  the shareholders will have the opportunity to meet the managing directors
of the Revenio Group Corporation at a coffee event.


A. Matters on the agenda of the general meeting

The following matters will be considered at the General Meeting:

1. Opening of the meeting

2. Calling the meeting to order

3. Election  of the persons to confirm the minutes and to supervise the counting
of votes

4. Recording the legal convening of the meeting and quorum

5. Recording the attendance at the meeting and adoption of the list of votes

6. Presentation  of the annual  accounts, the Report  of the Board of Directors,
and the auditor's report for the year 2014
  * Review by the President and CEO

7. Adoption of the annual accounts

8. Resolution  on  the  use  of  the  profit  shown on the balance sheet and the
payment of dividend
The  Board of  Directors proposes  to the  AGM that  a per-share dividend of EUR
0.45 be  paid  for  the  financial  year  2014. The  dividend  is  paid to those
shareholders  who,  on  the  dividend  record  date of 3/23/2015, are entered as
shareholders  on the Company's shareholder register as held by Euroclear Finland
Ltd. The Board proposes that the dividend payment date be 3/30/2015.

9. Resolution  on the discharge of the members of the Board of Directors and the
President and CEO from liability

10. Resolution  on the remuneration of the members of the Board of Directors and
on the grounds for compensation of travel expenses
The Board of Directors proposes that the remuneration paid to the members of the
Board  of Directors to be elected at the AGM for the term until the close of the
AGM  in 2016 be as follows:  EUR 36,000 for the Chairman  and EUR 18,000 for the
members  of the  Board of  Directors. The  Board of  Directors proposes that 40
percent  of Board members' emoluments  will be settled in  the form of shares in
the Company, while 60 percent will consist of a monetary payment.
Moreover,  the  Board  of  Directors  proposes  that  the travel expenses of the
regular  members of the Board of Directors be compensated in accordance with the
Finnish Tax Administration's decision regarding tax-exempt allowances for travel
expenses.

11. Resolution on the number of members of the Board of Directors
The  Board of  Directors proposes  that five  regular members  be elected to the
Board of Directors.

12. Election of the members of the Board of Directors
Shareholders  accounting for a  total of 23.78 percent  of all shares and voting
rights  in the Company have informed the  Company that they will propose the re-
election  of Pekka Tammela, Rolf Fryckman,  Ari Korhonen, Pekka Rönkä and Kyösti
Kakkonen.

13. Resolution on the remuneration of the auditor
The  Board of Directors proposes that remuneration for the auditor shall be paid
against the auditor's reasonable invoice.

14. Election of the auditor
The  Board of Directors proposes that  PricewaterhouseCoopers Oy, who have named
Authorized  Public Accountant Samuli Perälä as  the chief auditor, be re-elected
as the auditor.

15. Authorizing the Board of Directors to decide to repurchase the Company's own
shares
The  Board of Directors proposes  that the AGM authorize  the Board to decide to
repurchase  a maximum of 793.207 of  the Company's own shares  in one or several
tranches using the Company's unrestricted equity, in which case any buyback will
reduce the amount of the Company's distributable earnings.
The  company may  buy back  shares in  order to  develop its  capital structure,
finance   and  implement  any  corporate  acquisitions  or  other  transactions,
implement share-based incentive plans, or otherwise transfer or cancel them.
The Company may buy back shares, based on

 a. A bid submitted to all shareholders on equal terms and conditions in
    proportion to their current holdings in Company shares and at the same
    price, decided by the Board of Directors; or
 b. In public trading on marketplaces whose rules and regulations allow the
    Company to trade in its own shares. In such a case, the Company buys back
    shares through a directed purchase, that is, in a proportion other than its
    shareholders' holdings in Company shares, with the consideration for the
    shares based on their publicly quoted market price.

   The  Board  proposes  that  the  authorization be valid until 4/30/2016. This
authorization  shall supersede the  buyback authorization granted  at the AGM of
3/20/2014.

16. Authorization  to the Board of  Directors to decide on  a share issue and on
the  granting of  stock options  and other  special rights giving entitlement to
shares
The  Board of Directors proposes that the AGM authorize the Board to decide on a
share issue of a maximum of 793,207 shares or to grant special rights (including
stock  options) entitling holders to shares as referred to in Chapter 10 Section
1 of the Companies Act, in one or several tranches.
This  authorization  is  proposed  to  be  used  to  finance  and  implement any
prospective  corporate  acquisitions  or  other  transactions,  to implement the
company's  share-based incentive plans, or for  other purposes determined by the
Board.
The authorization is also proposed to grant the Board the right to decide on all
terms  and conditions  governing said  share issue  and the  granting of special
rights, including the subscribers or the grantees of said special rights and the
payable  consideration.  The  authorization  also  includes  the  right to waive
shareholders' pre-emptive subscription rights and covers the issue of new shares
and the transfer of any shares that may be held by the company.
The  Board  proposes  that  the  authorization  be  valid  until 4/30/2016. This
authorization  shall supersede the authorization to  decide on a share issue and
on  the granting of special  rights giving entitlement to  shares granted in the
AGM of 4/20/2014.

17. Amendment of the Articles of Association
The  Board of  Directors proposes  the following  amendment to  section 2 of the
Articles of Association:

   "The   company  engages  in  the  trade,  intermediation,  research,  product
development, commercialization and marketing of devices and equipment, products,
methods  and services related to health care and health technology, training and
consulting  related to health care, sales of expert services, and other business
related  or comparable to the health care sector. The company may act as a Group
parent  company and  produce administration  services, engage  in other business
operations,  own  and  manage  real  estate  and  securities and other financial
instruments,  and trade  in them.  The company  may engage in the aforementioned
activity either directly or through subsidiaries and associated companies."

18. Closing of the meeting


B. Documents of the General Meeting

The  abovementioned proposals for  resolution on the  AGM agenda and this notice
are  available on  the website  of Revenio  Group Corporation at www.revenio.fi.
Revenio  Group Corporation's Annual Report,  including the financial statements,
Report of the Board of Directors, and auditor's report, will be available on the
website no later than 2/26/2015. Proposals for resolution and the abovementioned
documents  will also be available at the AGM, and copies of them as well as this
notice will be sent to shareholders upon request. The Minutes of the AGM will be
available on the abovementioned website from 4/2/2015 onwards.

C. Instructions to meeting participants

1. Shareholders registered in the shareholder register

Shareholders who are registered in the Company's shareholder register maintained
by  Euroclear  Finland  Ltd  on  3/9/2015, have  the  right  to  attend the AGM.
Shareholders  whose shares are registered  in their personal book-entry accounts
in Finland are registered in the shareholder register of the Company.

Shareholders  who are registered in the  Company's shareholder register and wish
to participate in the AGM must register for the meeting no later than 3/16/2015
at  4:00 p.m., by  which time  registration notices  need to have been received.
Registration options for the General Meeting are:

a) through the Company's website at www.revenio.fi
b) via e-mail to elina.kari@revenio.fi or
c)  by mail to Revenio Group Corporation, General Meeting, Äyritie 22, FI-01510
Vantaa, Finland.

Upon  registration, shareholders should give their name, personal identity code,
address,  telephone number, name  of assistant or  proxy representative, if any,
and the personal identity code of the proxy representative. Personal information
given  by  shareholders  to  Revenio  Group  Corporation  shall  be used only in
connection  with  the  General  Meeting  and  with  the  processing  of  related
registrations. Shareholders, their representatives or proxy representatives must
be  able  to  prove  their  identity  and/or  proxy authorization at the meeting
venue.

2. Holders of nominee-registered shares

A holder of nominee-registered shares has the right to participate in the AGM by
virtue  of such shares based on which the holder would, on 3/9/2015, be entitled
to  be registered  in the  shareholder register  held by  Euroclear Finland Ltd.
Moreover,  in order  to participate  in the  AGM, holders  of nominee-registered
shares  are required to be temporarily registered,  based on such shares, in the
shareholder  register held by Euroclear Finland Ltd, no later than 3/16/2015, at
10:00 a.m.  For nominee-registered shares, this constitutes due registration for
the General Meeting.

Holders  of nominee-registered shares are advised to request, without delay, all
necessary  instructions pertaining to registration  in the temporary shareholder
register,  the  issuing  of  proxy  documents,  and registration for the General
Meeting  from their  asset managers.  The asset  manager's account operator must
sign  up holders  of nominee-registered  shares who  wish to  participate in the
General Meeting for registration to the Company's temporary shareholder register
no later than on the aforementioned date and time.

3. Proxy representation and powers of attorney

Shareholders may participate in the General Meeting and exercise their rights at
the meeting by way of proxy representation. A shareholder's proxy representative
shall  present a dated power of attorney or shall otherwise in a reliable manner
prove  that he/she is authorized to  represent the shareholder. If a shareholder
participates  in the  General Meeting  by way  of several proxy representatives,
representing  the shareholder with shares  in different securities accounts, the
shares  by which  each proxy  representative represents  the shareholder must be
identified upon registration.

Proxy  documents,  if  any,  should  be  delivered as originals to Revenio Group
Corporation,  General Meeting, Äyritie  22, FI-01510 Vantaa, Finland, before the
last date for registration.

4. Other instructions and information

Pursuant  to Chapter 5, Section 25  of the Finnish  Companies Act, a shareholder
who  is present at the  General Meeting has the  right to request information on
matters on the meeting's agenda.

On  the date of  this notice, 2/24/2015, the  total number of  shares in Revenio
Group Corporation is 7,932,078, representing the same number of votes.


Helsinki, 2/24/2015

REVENIO GROUP CORPORATION
BOARD OF DIRECTORS


For additional information:
President&CEO Olli-Pekka Salovaara, +358 (0)40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi


The Revenio Group in brief

Revenio  is a Finnish health tech group  whose core business lies in tonometers.
The  Revenio  Health  Tech  segment  comprises  the business operations of Icare
Finland  Oy and Oscare  Medical Oy, which  specializes in osteoporosis screening
and    assessment.    In   addition,   Revenio   has   identified   new   growth
opportunities relating   to   health  tech  in  which  common  denominators  are
screening,  follow-up and the  global need to  make cost savings  in health care
through preventive measures. Revenio seeks vigorous growth in health technology,
both organically and through acquisitions and mergers.

In  2014, the Revenio  Group's net  sales totaled  MEUR 16.0, with its operating
margin   for   continuing   operations  standing  at  27.5%. The  Revenio  Group
Corporation is listed on Nasdaq Helsinki.